Basil Michelle L — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Basil Michelle L has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Michelle L. Basil is an American corporate attorney who, according to the most recent SEC filing dated 2026-05-19, serves as the Executive Vice President and General Counsel of Haemonetics Corporation. In this role, she oversees the company’s legal, compliance, governance, and risk management functions and is a key member of the executive leadership team guiding corporate strategy and regulatory matters in Haemonetics’ medical-device and blood-management business.

Board memberships

• Haemonetics Corporation

Awards & honors

• Oversees legal, compliance, and governance for Haemonetics
• Key participant in securities filings and corporate strategies
• Guides risk management and regulatory affairs for a medical-device company

Recent Transactions

Companies — Last 90 Days

• HAEMONETICS CORP (HAE) — 1 filings, last 2026-05-19

Frequently Asked Questions

Who is Basil Michelle L?

Michelle L. Basil is an American corporate attorney who, according to the most recent SEC filing dated 2026-05-19, serves as the Executive Vice President and General Counsel of Haemonetics Corporation. In this role, she oversees the company’s legal, compliance, governance, and risk management functions and is a key member of the executive leadership team guiding corporate strat…

How many SEC Form 4 filings has Basil Michelle L submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Basil Michelle L's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week